Matinas BioPharma (MTNB) Tops Q2 EPS by 1c
Matinas BioPharma (NYSE: MTNB) reported Q2 EPS of ($0.02), $0.01 better than the analyst estimate of ($0.03).
For earnings history and earnings-related data on Matinas BioPharma (MTNB) click here.
Matinas BioPharma (NYSE: MTNB) reported Q2 EPS of ($0.02), $0.01 better than the analyst estimate of ($0.03).
For earnings history and earnings-related data on Matinas BioPharma (MTNB) click here.